SERPINF1, serpin family F member 1, 5176

N. diseases: 294; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE In addition, circulating as well as tumor expression levels of PEDF have been inversely associated with tumor growth and metastasis. 30892156 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Pigment epithelium-derived factor (PEDF) is a secreted anticancer protein that can regulate lung cancer progression; however, the role of PEDF in non-small cell lung cancer (NSCLC), including metastasis and cancer cell-derived exosome secretion, is unclear. 30439539 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE PEDF demonstrated anti-proliferative and pro-apoptotic effects against human prostate and breast cancer cells, tumors which are known to metastasize to bone as the preferred secondary site. 31028961 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Correction: Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis. 30013023 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE In conclusion, our findings indicate for the first time that PEDF functions as tumor-suppressor gene in the occurrence of EMT and metastasis in NPC. 28569772 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE In conclusion, our results demonstrate a novel functional role of PEDF/LR axis in driving metastasis through ERK1/2-mediated EMT in HCC and provided a promising prognostic marker in HCC. 28771223 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE Inhibiting TXNDC5 expression simultaneously led to the increased expression of SERPINF1 (serpin peptidase inhibitor, clade F) and TRAF1 (TNF receptor-associated factor 1), which have been reported to inhibit angiogenesis and metastasis as well as induce apoptosis. 29207620 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE MSCs engineered to secrete PEDF through adenoviral transduction significantly inhibited tumor metastasis and malignant ascites formation in CT26 CRPC mice. 26756933 2016
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE This review aims to summarize recent findings, the role of PEDF in cervical cancer treatment, and enhance the current understanding of the antitumor properties of PEDF such as inhibiting angiogenesis and metastasis, inducing tumor cell apoptosis and differentiation, and modulating cellular immunity against cervical cancer. 26122658 2015
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Metastases were reduced in PEDF-DTX-5 mg/kg compared with other treatments, suggesting that PEDF-DTX delayed metastases formation. 24810046 2014
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE OCM-1 cells expressing WT-PEDF, EEA-PEDF, or EEE-PEDF displayed significantly reduced tumor growth and metastasis in the melanoma xenograft of nude mice models, with the PEDF mutants displaying much stronger effects than the wild type. 22952124 2012
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis. 19661223 2010
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE In this study we report, for the first time, the multitargeted role of PEDF in the inhibition of growth, angiogenesis and metastasis of two orthotopic models of osteosarcoma (rat UMR 106-01 and human SaOS-2). 17479108 2007
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Among them, PAI-2 and DRHC were confirmed to be upregulated with real-time PCR and Western blot, suggesting a possible association with PEDF-induced signaling for cell motility and metastasis. 17471021 2007
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE Angiostatin increases PEDF mRNA in melanoma metastases. 16735992 2006
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Moreover, the growth of PEDF-overexpressing pancreatic adenocarcinoma cells was significantly suppressed in comparison with control cells in peritoneal metastasis models. 16361561 2005
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype RGD In human cancer tissues, by immunohistochemistry and real-time quantitative reverse transcription-PCR, patients without metastases at diagnosis had higher tumor pigment epithelium-derived factor levels than tumors from patients with metastases at diagnosis. 15313905 2004
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE PEDF-mediated inhibition of melanoma metastases could thus have a major impact on existing therapies for melanoma. 15313901 2004